Related Experiment Video

Updated: Aug 20, 2026

Local Hyperthermia for Warts Treatment
04:25

Local Hyperthermia for Warts Treatment

Published on: November 8, 2024

Therapy of cutaneous human Papillomavirus infections

Allison Rivera1, Stephen K Tyring

  • 1Department of Dermatology, Baylor College of Medicine, Houston, TX 77030, USA.

Dermatologic Therapy
|December 2, 2004
PubMed

Insights

Human Papillomaviruses (HPV) cause warts, with no cure available. New immunomodulatory treatments show higher efficacy for HPV lesions, while vaccines offer promising prevention against oncogenic types.

Area of Science:

  • Virology
  • Dermatology
  • Immunology

Background:

  • Human Papillomaviruses (HPV) are common DNA viruses causing various skin and genital lesions.
  • Current HPV treatments focus on symptom management as no cure exists, and therapies do not impact transmission.
  • Traditional treatments like cryotherapy and salicylic acid lack proven superiority for HPV-related warts.

Purpose of the Study:

  • To review current treatment modalities for Human Papillomavirus (HPV) infections.
  • To evaluate the efficacy of traditional and emerging therapies for HPV-induced cutaneous lesions.
  • To highlight the potential of immunomodulatory compounds and vaccines in managing and preventing HPV.

Main Methods:

  • Review of traditional destructive therapies for HPV lesions.
  • Analysis of recent studies on immunomodulatory compounds with antiviral properties.
  • Examination of clinical trial data for HPV vaccines.

Main Results:

  • Traditional HPV treatments (e.g., cryotherapy, salicylic acid) lack demonstrated superiority.
  • Immunomodulatory compounds show higher efficacy, achieving up to 77% clearance rates with low recurrence.
  • Clinical trials indicate significant safety and efficacy for vaccines preventing oncogenic HPV acquisition.

Conclusions:

  • Emerging immunomodulatory treatments offer improved outcomes for HPV infections compared to traditional methods.
  • Vaccines represent a key strategy for preventing oncogenic Human Papillomavirus infections.
  • Further research into novel therapies and preventative measures for HPV is warranted.

More Related Videos

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

Related Concept Videos

Herpes01:28

Herpes

Herpes simplex type 1 (HSV‑1) is a widespread pathogen responsible for orolabial lesions. It is an enveloped, double-stranded DNA (dsDNA) virus belonging to the family Herpesviridae. Once the virus infects a host cell, its double‑stranded DNA genome is delivered into the nucleus, where a coordinated cascade of immediate‑early, early, and late gene expression directs viral DNA replication, structural protein synthesis, and virion assembly. After primary infection of epithelial cells, HSV-1...
Genital Herpes01:23

Genital Herpes

Genital herpes is a sexually transmitted infection primarily caused by herpes simplex virus type 2 (HSV-2), though herpes simplex virus type 1 (HSV-1) is increasingly implicated in genital infections, particularly among younger populations. Transmission occurs mainly through sexual contact, with asymptomatic viral shedding serving as a major route of spread. This characteristic makes HSV-2 difficult to control at a population level, as individuals may unknowingly transmit the virus even in the...
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...